|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
BR0314864A
(pt)
|
2002-10-03 |
2005-08-02 |
Novartis Ag |
Compostos orgânicos
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2004072066A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
|
AU2005229415B2
(en)
|
2004-04-02 |
2009-05-14 |
Novartis Ag |
Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
|
|
US7750020B2
(en)
|
2004-04-02 |
2010-07-06 |
Novartis Ag |
Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes
|
|
CN101137631A
(zh)
*
|
2004-12-03 |
2008-03-05 |
转化技术制药公司 |
杂芳族葡糖激酶激活剂
|
|
CA2614746C
(en)
|
2005-07-09 |
2011-05-10 |
Astrazeneca Ab |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
|
CA2621227A1
(en)
*
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
Thiazole derivative
|
|
JP2007063225A
(ja)
*
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
JP2009509988A
(ja)
|
2005-09-29 |
2009-03-12 |
サノフィ−アベンティス |
フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
|
|
GT200600428A
(es)
*
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
|
GT200600429A
(es)
*
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
JP2009515997A
(ja)
*
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
US8034822B2
(en)
|
2006-03-08 |
2011-10-11 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
US8211925B2
(en)
*
|
2006-04-28 |
2012-07-03 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
|
EP2049518B1
(en)
*
|
2006-05-31 |
2011-08-31 |
Takeda San Diego, Inc. |
Indazole and isoindole derivatives as glucokinase activating agents.
|
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
BRPI0715531A2
(pt)
|
2006-07-24 |
2014-06-24 |
Hoffmann La Roche |
Composto, composição farmacêutica, método para o tratamento de uma enfermidade e/ou distúrbio metabólico, processo para a preparação de compostos e uso do composto
|
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
|
US20080107725A1
(en)
*
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
|
US7902248B2
(en)
*
|
2006-12-14 |
2011-03-08 |
Hoffmann-La Roche Inc. |
Oxime glucokinase activators
|
|
US8163779B2
(en)
|
2006-12-20 |
2012-04-24 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
WO2008074694A1
(en)
*
|
2006-12-20 |
2008-06-26 |
F. Hoffmann-La Roche Ag |
Crystallization of glucokinase activators
|
|
TW200831081A
(en)
*
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
|
WO2008084872A1
(ja)
|
2007-01-10 |
2008-07-17 |
Mitsubishi Tanabe Pharma Corporation |
ヒドラゾン誘導体
|
|
KR20190126460A
(ko)
|
2007-02-09 |
2019-11-11 |
메타베이시스 테라퓨틱스, 인크. |
글루카곤 수용체의 길항제
|
|
MX2009009525A
(es)
*
|
2007-03-07 |
2009-09-16 |
Kyorin Seiyaku Kk |
Activador de glucocinasa.
|
|
US8173645B2
(en)
*
|
2007-03-21 |
2012-05-08 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
EP2145012A2
(en)
|
2007-04-04 |
2010-01-20 |
F. Hoffmann-Roche AG |
Microbial reduction of an acetoxyketone
|
|
JP2010524861A
(ja)
*
|
2007-04-20 |
2010-07-22 |
メルク フロスト カナダ リミテツド |
ステアロイル−補酵素ａデルタ−９デサチュラーゼの阻害剤としての新規な複素環式芳香族化合物
|
|
WO2009022179A2
(en)
*
|
2007-08-14 |
2009-02-19 |
Astrazeneca Ab |
Glucokinase activators in the treatment of osteoarthritis
|
|
US8501955B2
(en)
*
|
2007-10-08 |
2013-08-06 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal application
|
|
AU2009205070A1
(en)
|
2008-01-18 |
2009-07-23 |
Astellas Pharma Inc. |
Phenyl acetamide derivative
|
|
US8258134B2
(en)
|
2008-04-16 |
2012-09-04 |
Hoffmann-La Roche Inc. |
Pyridazinone glucokinase activators
|
|
US7741327B2
(en)
*
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
SI2275414T1
(sl)
|
2008-04-28 |
2015-10-30 |
Kyorin Pharmaceutical Co., Ltd., |
Ciklopentilakrilamidni derivat
|
|
CA2770298C
(en)
|
2008-08-13 |
2017-06-20 |
Metabasis Therapeutics, Inc. |
Glucagon antagonists
|
|
UA104742C2
(uk)
*
|
2008-12-19 |
2014-03-11 |
Эли Лилли Энд Компани |
Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
|
|
US20110021570A1
(en)
*
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
US20110040091A1
(en)
|
2009-08-13 |
2011-02-17 |
Stephan Bachmann |
Process for the preparation of (r)-2-phenyl propionic acid derivatives
|
|
US20110054174A1
(en)
|
2009-08-28 |
2011-03-03 |
Stephan Bachmann |
Process for the preparation of a glucokinase activator compound
|
|
CN102812014B
(zh)
|
2009-10-30 |
2016-01-20 |
多美恩医疗公司 |
新颖的肟衍生物及其作为代谢型谷氨酸受体的别构调节剂的用途
|
|
US8222416B2
(en)
|
2009-12-14 |
2012-07-17 |
Hoffmann-La Roche Inc. |
Azaindole glucokinase activators
|
|
CA2800498C
(en)
|
2010-03-31 |
2021-11-16 |
The Scripps Research Institute |
Reprogramming cells
|
|
US8592396B2
(en)
|
2010-04-14 |
2013-11-26 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
|
US8178689B2
(en)
|
2010-06-17 |
2012-05-15 |
Hoffman-La Roche Inc. |
Tricyclic compounds
|
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
|
BR112013011868A2
(pt)
*
|
2010-11-16 |
2016-08-23 |
Acetylon Pharmaceuticals Inc |
compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
|
|
US8470866B2
(en)
|
2011-05-03 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Isoindolinone derivatives
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
RU2014121984A
(ru)
|
2011-10-31 |
2015-12-10 |
Ксенон Фармасьютикалз Инк. |
Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
|
|
CN104718188B
(zh)
|
2012-05-22 |
2018-08-21 |
基因泰克公司 |
N-取代的苯甲酰胺类及其在治疗疼痛中的用途
|
|
KR101663436B1
(ko)
*
|
2012-07-06 |
2016-10-06 |
제넨테크, 인크. |
N-치환된 벤즈아미드 및 이의 사용 방법
|
|
RU2015143906A
(ru)
|
2013-03-14 |
2017-04-18 |
Дженентек, Инк. |
Замещенные триазолопиридины и способы их применения
|
|
BR112015023397A2
(pt)
|
2013-03-15 |
2017-07-18 |
Genentech Inc |
benzoxazois substituídos e métodos de uso dos mesmos
|
|
MX368243B
(es)
|
2013-08-23 |
2019-09-25 |
Parion Sciences Inc |
Agentes mucolíticos de ditiol.
|
|
ES2929576T3
(es)
|
2013-10-08 |
2022-11-30 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
|
|
WO2015054474A1
(en)
|
2013-10-10 |
2015-04-16 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
|
US10660890B2
(en)
|
2013-10-24 |
2020-05-26 |
National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) |
Treatment of polycystic diseases with an HDAC6 inhibitor
|
|
WO2015078374A1
(en)
|
2013-11-27 |
2015-06-04 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
EP2878339A1
(en)
|
2013-12-02 |
2015-06-03 |
Siena Biotech S.p.A. |
SIP3 antagonists
|
|
CR20160308A
(es)
|
2013-12-03 |
2016-11-08 |
Acetylon Pharmaceuticals Inc |
Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
|
|
US9464073B2
(en)
|
2014-02-26 |
2016-10-11 |
Acetylon Pharmaceuticals, Inc. |
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
WO2015191900A1
(en)
|
2014-06-12 |
2015-12-17 |
Ligand Pharmaceuticals, Inc. |
Glucagon antagonists
|
|
JP2017525677A
(ja)
|
2014-07-07 |
2017-09-07 |
ジェネンテック， インコーポレイテッド |
治療用化合物及びその使用方法
|
|
SG11201700094TA
(en)
|
2014-07-07 |
2017-02-27 |
Acetylon Pharmaceuticals Inc |
Treatment of leukemia with histone deacetylase inhibitors
|
|
LT3186257T
(lt)
|
2014-08-27 |
2019-04-25 |
Prexton Therapeutics Sa |
Nauji chromono oksimo dariniai ir jų panaudojimas kaip metabotropinių gliutamato receptorių alosterinių moduliatorių
|
|
US9937174B2
(en)
|
2014-12-05 |
2018-04-10 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine
|
|
CA2974210A1
(en)
|
2015-01-30 |
2016-08-04 |
Parion Sciences, Inc. |
Novel monothiol mucolytic agents
|
|
CA2984424A1
(en)
|
2015-04-30 |
2016-11-03 |
Parion Sciences, Inc. |
Novel prodrugs of dithiol mucolytic agents
|
|
HK1252567A1
(zh)
|
2015-05-22 |
2019-05-31 |
基因泰克公司 |
被取代的苯甲酰胺和其使用方法
|
|
US10272084B2
(en)
|
2015-06-01 |
2019-04-30 |
Regenacy Pharmaceuticals, Llc |
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
|
|
JP2018526371A
(ja)
|
2015-08-27 |
2018-09-13 |
ジェネンテック， インコーポレイテッド |
治療化合物及びその使用方法
|
|
RU2018110580A
(ru)
|
2015-08-27 |
2019-09-30 |
Прекстон Терапьютикс Са |
Проникающее в мозг производное оксима хромона для терапии леводопа-индуцированной дискинезии
|
|
CA2999769A1
(en)
|
2015-09-28 |
2017-04-06 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
EP3380466A1
(en)
|
2015-11-25 |
2018-10-03 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
EP3436432B1
(en)
|
2016-03-30 |
2021-01-27 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
EP3445364A4
(en)
|
2016-04-19 |
2019-11-27 |
Acetylon Pharmaceuticals, Inc. |
HDAC INHIBITORS, ONLY OR IN COMBINATION WITH BTK INHIBITORS, FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
|
|
EP3487862A1
(en)
|
2016-07-22 |
2019-05-29 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
|
PE20190980A1
(es)
|
2016-10-17 |
2019-07-09 |
Genentech Inc |
Compuestos terapeuticos y metodos para utilizarlos
|
|
JP2020511511A
(ja)
|
2017-03-24 |
2020-04-16 |
ジェネンテック， インコーポレイテッド |
ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体
|
|
WO2019160940A1
(en)
|
2018-02-13 |
2019-08-22 |
Ligand Pharmaceuticals Incorporated |
Glucagon receptor antagonists
|
|
AR114263A1
(es)
|
2018-02-26 |
2020-08-12 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos
|
|
US10947251B2
(en)
|
2018-03-30 |
2021-03-16 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|